Reed Smith Client Alerts

With the proposed European patent litigation system now stalled for at least the near future, a key question for U.S. life sciences companies in their European patent litigation strategy will continue to be in which countries to bring patent infringement cases. The German courts offer a variety of advantages for U.S. pharmaceutical and medical device companies.

Authors: Anette Gärtner

Type: Client Alerts

Germany: A country in which civil proceedings cannot be conducted in English, because German is the mandatory court language. Nevertheless, two-thirds of all patent infringement cases in Europe are brought in Germany. Not only our fellow Europeans, but also international companies headquartered in the United States, choose to use German courts to enforce their patents. Why? Let us shed some light on the patent enforcement landscape in Europe, and Germany in particular – a leading patent jurisdiction.